Dividend Advisor Hotline – Friday, January 4, 2019

PFIZER INC., $43.00, New York symbol PFE, is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis).

Starting with the March 2019 payment, Pfizer will increase its quarterly dividend by 5.9%,… Read More

5 top Canadian dividend stocks to invest in

5 top Canadian dividend stocks to invest in

Here are 5 Canadian dividend stocks we recommend holding in your portfolio
One of the key points in our three-part investment advice is to invest mainly in well-established dividend-paying stocks. Successful investors pay a lot of attention to dividend yields from Canadian dividend stocks. Dividends can… Read More

Savvy acquisitions set to spur their dividends

BANK OF NOVA SCOTIA $69 (Toronto symbol BNS; Income-Growth Portfolio, Finance sector; Shares outstanding: 1.2 billion; Market cap: $82.8 billion; Dividend yield: 4.9%; Dividend Sustainability Rating: Above Average; www.scotiabank.com) is the third-largest of Canada’s five big banks with assets of $946.7 billion.
Bank of Nova Scotia last raised its… Read More

BNS purchase targets key market

BANK OF NOVA SCOTIA $74 (Toronto symbol BNS; Conservative Growth and Income Portfolios, Finance sector; Shares outstanding: 1.2 billion; Market cap: $88.8 billion; Price-to-sales ratio: 3.6; Dividend yield: 4.5%; TSINetwork Rating: Above Average; www.scotiabank.com) continues to expand its wealth management operations, which supply 12% of its total… Read More

Scotiabank targets key growth areas

Bank of Nova Scotia continues to expand in two main areas: Latin America and wealth management. This includes recent acquisitions of banking operations in Chile and Peru as well as its $950 million all-stock purchase of wealth management firm Jarislowsky Fraser. These additions further diversify… Read More